Related Experiment Video

Updated: Apr 17, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

(Meta)-analysis of safety and efficacy following edge-to-edge mitral valve repair using the MitraClip system

Dorothee H L Bail1

  • 1Competence-Center Quality Assurance, Medical Service of Statutory Healthcare Insurance, Tuebingen and Stuttgart, Germany.

Journal of Interventional Cardiology
|February 18, 2015
PubMed
Abstract

Insights

The MitraClip-System (MCS) demonstrates good short-term safety and efficacy, with low mortality rates in patients unsuitable for surgery. Results suggest MCS is a viable option, comparable to open mitral valve repair for high-risk individuals.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • The safety and efficacy of the MitraClip-System (MCS) remain subjects of ongoing debate.
  • A lack of randomized controlled trials necessitates further investigation into MCS performance.

Purpose of the Study:

  • To systematically analyze the safety and efficacy of the MitraClip-System (MCS).
  • To evaluate short-term and long-term outcomes of MCS treatment.

Main Methods:

  • A systematic literature search was performed across major medical and scientific databases.
  • Data on mortality, mitral regurgitation (MR), adverse events (AE), NYHA class, and reoperation rates were collected at 30 days, 6 months, and 12 months post-procedure.
  • A quantitative meta-analysis was conducted to summarize findings.

Main Results:

  • Analysis of 26 studies involving 3821 patients showed post-procedural MR <2+ in 86.4% of cases.
  • Within 30 days, 66.3% of patients were in NYHA class I/II, with an AE rate of 18.3%, mortality rate of 2.8%, and reoperation rate of 3.5%.
  • At 6 and 12 months, freedom from severe MR was 80.2%, from NYHA class III/IV was 78.6%, and freedom from death was 82.6%.

Conclusions:

  • MitraClip-System (MCS) treatment is associated with favorable short-term outcomes and low mortality.
  • MCS is a safe and effective option for patients with limited surgical alternatives, showing comparable results to open mitral valve repair (oMVR) in older, higher-risk populations.
  • Further prospective randomized controlled trials are essential to assess long-term device durability and potential adverse events.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K
Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment18:50

Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment

Published on: September 25, 2009

14.2K

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
617
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
484
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.0K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K